These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 7669326)
1. [Antiaggregants in the prevention of ischemic cardiopathy and systemic thromboembolism]. Pérez Gómez F; Pérez Vizcaíno F Rev Port Cardiol; 1995; 14(7-8):525-31. PubMed ID: 7669326 [TBL] [Abstract][Full Text] [Related]
2. [Prevention of thromboembolism in non-rheumatic atrial fibrillation: an update]. Pengo V; De Caterina R Ital Heart J Suppl; 2001 Sep; 2(9):972-9. PubMed ID: 11675834 [TBL] [Abstract][Full Text] [Related]
3. [Platelet inhibitors or anticoagulants in prevention after myocardial infarct? The 1991 state of the art]. van de Loo J; Kienast J Z Gesamte Inn Med; 1992 Jan; 47(1):1-5. PubMed ID: 1570716 [TBL] [Abstract][Full Text] [Related]
4. Atrial fibrillation and anticoagulation. Garnier LF; Rouesnel P; Espitalier F Arch Mal Coeur Vaiss; 2004 Oct; 97(10):1001-5. PubMed ID: 16008178 [TBL] [Abstract][Full Text] [Related]
5. Antithrombotic therapy for heart failure in sinus rhythm. Subramaniam V; Davis RC; Shantsila E; Lip GY Fundam Clin Pharmacol; 2009 Dec; 23(6):705-17. PubMed ID: 19735305 [TBL] [Abstract][Full Text] [Related]
6. [Atrial fibrillation and thromboembolism: a multicenter cooperative study. Research Group for Antiarrhythmic Drug Therapy]. J Cardiol; 1998 Apr; 31(4):227-38. PubMed ID: 9594372 [TBL] [Abstract][Full Text] [Related]
8. [Atrial fibrillation and thromboembolic events prevention. State of the art]. Matteoli S; Trappolini M; Chillotti FM Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381 [TBL] [Abstract][Full Text] [Related]
9. [Survey of atrial fibrillation and thromboembolism in the elderly: a multicenter cooperative study. Research Group for Antiarrhythmic Drug Therapy]. J Cardiol; 1999 Jan; 33(1):27-35. PubMed ID: 10028459 [TBL] [Abstract][Full Text] [Related]
10. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative]. Själander A; Wallentin L; Rosenqvist M; Svensson P Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862 [No Abstract] [Full Text] [Related]
11. Aspirin for atrial fibrillation. Douglas M; Strelnick A J Fam Pract; 2000 Jan; 49(1):7-8. PubMed ID: 10678329 [No Abstract] [Full Text] [Related]
12. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis. Ruiz-Nodar JM; Marín F; Hurtado JA; Valencia J; Pinar E; Pineda J; Gimeno JR; Sogorb F; Valdés M; Lip GY J Am Coll Cardiol; 2008 Feb; 51(8):818-25. PubMed ID: 18294566 [TBL] [Abstract][Full Text] [Related]
13. [Prevention of thromboembolism in atrial fibrillation of non-valvular etiology]. Cattaneo M Ann Ital Med Int; 1996 Oct; 11 Suppl 2():15S-17S. PubMed ID: 9004815 [TBL] [Abstract][Full Text] [Related]
14. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials. Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL; Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169 [TBL] [Abstract][Full Text] [Related]
15. [What anticoagulant therapy should be used for what form of atrial fibrillation?]. Frantz E Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S10-1. PubMed ID: 10818997 [No Abstract] [Full Text] [Related]
16. Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study. Pérez-Gómez F; Alegría E; Berjón J; Iriarte JA; Zumalde J; Salvador A; Mataix L; J Am Coll Cardiol; 2004 Oct; 44(8):1557-66. PubMed ID: 15489085 [TBL] [Abstract][Full Text] [Related]
17. [When not to prescribe chronic treatment to the patient with atrial fibrillation]. Scardi S; Mazzone C G Ital Cardiol; 1999 Nov; 29(11):1378-80. PubMed ID: 10609146 [No Abstract] [Full Text] [Related]
18. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?]. Selçuk H; Selçuk MT; Maden O Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079 [TBL] [Abstract][Full Text] [Related]
19. [Antithrombotic therapy for ischemic cerebrovascular accident]. Mas JL Arch Mal Coeur Vaiss; 2002 Nov; 95 Spec No 7():53-7. PubMed ID: 12500606 [TBL] [Abstract][Full Text] [Related]
20. [Italian Study on Atrial Fibrillation (SIFA): status report]. Amabile G; Matteoli S; Fattapposta F; Lavezzari M; Trappolini M; Heiman F; Morocutti C Cardiologia; 1993 Dec; 38(12 Suppl 1):327-32. PubMed ID: 8020032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]